https://www.optimumcomms.com/wp-content/uploads/2023/02/Nordic-Bioscinece_Logo_300x180px-2.png
180
300
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2023-06-15 11:06:172023-06-19 15:20:43Nordic Bioscience receives Letter of Support from the FDA for the PRO-C3 biomarker in tumor fibrosis
https://www.optimumcomms.com/wp-content/uploads/2023/02/Invizius_Logo_300px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-13 08:37:362023-06-13 09:21:34Invizius announces ‘Angry Blood’ Haemodialysis Study and recruits its 300th patient
https://www.optimumcomms.com/wp-content/uploads/2023/09/WiLD_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-13 08:31:432023-09-27 09:06:29Women in Life Science Denmark (WiLD) receives grant from The Lundbeck Foundation to support and advance its Female Leadership Mentoring Program
https://www.optimumcomms.com/wp-content/uploads/2023/02/FM_Logo_300px.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-12 07:46:182023-06-16 17:25:23Futura’s Fast-Acting Topical Gel for the Treatment of Erectile Dysfunction Granted Marketing Authorisation by the US FDA for Over the Counter Sale
https://www.optimumcomms.com/wp-content/uploads/2023/06/Vicore_Pharma_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-09 09:00:282023-06-15 11:25:24Vicore has carried out directed share issuances of in total 29,875,000 shares at a subscription price of SEK 16.75 per share, raising gross proceeds of SEK 500 million
https://www.optimumcomms.com/wp-content/uploads/2023/06/Vicore_Pharma_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-07 07:09:112023-06-09 14:22:30Vicore further strengthens patent protection for C21
https://www.optimumcomms.com/wp-content/uploads/2023/02/Biocomposites_Logo_300px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-06 08:10:042023-06-08 17:03:03Biocomposites adds proprietary NanoBone® technology to its portfolio through the acquisition of Artoss GmbH
https://www.optimumcomms.com/wp-content/uploads/2023/06/Synaffix_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-01 08:52:262023-06-16 17:26:06Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
https://www.optimumcomms.com/wp-content/uploads/2023/02/Ionctura_Logo_300px-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-01 08:27:052023-06-19 09:18:22iOnctura To Present Research At Leading Scientific Conferences In June 2023
https://www.optimumcomms.com/wp-content/uploads/2023/02/Ariceum_Logo_300x180px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-01 08:12:072023-06-19 09:19:25Ariceum Therapeutics Expands Pipeline with Acquisition of Theragnostics Ltd
https://www.optimumcomms.com/wp-content/uploads/2023/02/Zephyrus_Logo_300x180px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-30 11:30:462023-06-08 17:07:39Zephyrus Innovations appoints David Whitaker as Chief Technology Officer
https://www.optimumcomms.com/wp-content/uploads/2023/02/adcendo_Logo_300px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-30 08:05:472023-06-08 17:08:25Adcendo ApS Announces Option License Agreement with Duality Biologics to Enhance Optionality to Further Expand First-in-class ADC Pipeline
https://www.optimumcomms.com/wp-content/uploads/2023/06/Destiny_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-25 08:58:172023-06-08 17:07:13Destiny Pharma plc – Dr Debra Barker Appointed Interim CEO
https://www.optimumcomms.com/wp-content/uploads/2023/02/Verona_Logo_300-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-24 13:10:522023-06-08 17:08:51Verona Pharma to Present at Jefferies Healthcare Conference
https://www.optimumcomms.com/wp-content/uploads/2023/06/InProTher_Logo_300x180px-80x80-5.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-24 09:19:112023-06-09 14:27:12InProTher announces EUR 6MSeed financing with the participation of the European Innovation Council Fund to develop first-in-class cancer immunotherapy
https://www.optimumcomms.com/wp-content/uploads/2023/06/Poolbeg_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-24 08:39:242023-06-19 09:19:53Poolbeg Pharma Plc – Board Appointment
https://www.optimumcomms.com/wp-content/uploads/2023/06/Vicore_Pharma_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-23 09:19:462023-06-09 14:26:17Vicore obtains significant new patent protection for C21 in the US
https://www.optimumcomms.com/wp-content/uploads/2023/06/Scarlet_Logo_300x180px-80x80-5.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-23 09:10:142023-06-19 09:21:17Scarlet Therapeutics Announces Seed Financing to Advance Development of Therapeutic Red Blood Cell Platform
https://www.optimumcomms.com/wp-content/uploads/2023/02/ONA_Logo_300px-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-23 08:36:052023-06-19 09:27:12ONA Therapeutics Announces the Appointment of Dr Pamela Klein to its Board of Directors
https://www.optimumcomms.com/wp-content/uploads/2023/05/Engimmune_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-23 08:34:032023-06-09 14:49:17Engimmune Therapeutics Announces the Appointment of Dr Annalisa D’Andrea to its Board of DirectorsFor more information about Optimum Strategic Communications, please get in touch.
